August 2022 #MoleculesOfTheMonth | https://t.co/tIDCXd3z9i A covalent, proof-of-concept KRASG12R inhibitor, an oral dihydroorotate dehydrogenase inhibitor being developed for AML, and a first-in-class YAP-TEAD protein-protein are some examples of this month's MOTM. #drughunter https://t.co/xNaaDiYvjG
Articles to help early drug hunters on understanding drug likeness and lead optimization techniques. Girinath
Friday, 30 September 2022
Tuesday, 27 September 2022
Key Research Articles
Drug Discovery Technology Review: Emerging Tools and Modalities in 2022Q2/Q3 | https://t.co/8fj0zKPIJD To keep you up to date on what’s happening in the biopharmaceutical industry, we’ve reviewed some of the most exciting updates from the past few months. #drughunter https://t https://t.co/ZDs7m0M0Em
Key Research Articles
Today (9/27) at 8:00AM PST (11:00AM EST): Recent Highlights in Drug Discovery: Q2/Q3 2022 We'll cover drug discovery highlights from Q2/3 of 2022, including scientific gems from recent drug approvals, Molecules of the Month, and more. Register: https://t.co/lToduYtXkF https:// https://t.co/nkXhQjME3k
Wednesday, 21 September 2022
Key Research Articles
RT @giribio: Well said "Don't get carried away by potency when selecting hits & leaving the kinase flatlands opens the door to exquisite" #drugdiscovery #compchem #medchem #cadd https://t.co/8ZTAKyJm5d
Tuesday, 20 September 2022
Key Research Articles
Do you want to learn basics of #compchem and #DFT in computational chemistry... Please go through the best practices... https://t.co/Uw7Dk3vjBY #abinitio #TuesdayMotivaton #learn #skill #quantumchemistry
Key Research Articles
Great opportunity for the young minds in #India to interact with the Nobel Laureates. Prepare well and apply. Best wishes. https://t.co/p6OTbGTDcz
Monday, 19 September 2022
Key Research Articles
Small Molecule and Biotechnology-Based Therapeutics for Immunology: 2021 IPO Review Pt. VI | https://t.co/wdDBRU7ZFx Dive into the 2021 IPOs for small molecule and biotech-based drugs by immunology-focused companies, including S1P1 modulators, an IL-17 antagonist, and more https https://t.co/LbiN9lg1By
Saturday, 17 September 2022
Key Research Articles
This poll says Good understanding of #medchem by a #compchem is important for drug discovery projects. https://t.co/JUxCFbb3sv
Wednesday, 14 September 2022
Key Research Articles
Drug Hunter Letters #3 - September 2022 | https://t.co/0gTBPMhQSe Drug Hunter readers Simon Bury, Callie Bryan, Bryan McKibben, Jesse Keicher, Abbas Kazimi, and Leon Wang share insightful thoughts on recent articles #drughunter https://t.co/p1VncYoSWl Source: drughuntersite https://t.co/FPv2gXQYuy
Friday, 9 September 2022
Key Research Articles
First Disclosures from ESMC-IFMC Nice, 2022 | https://t.co/X0VJJOp2KF Our overview of this year’s EMSC-IFMC conference in Nice, France, covers the two First Disclosure sections, where companies first shared the structures of their latest clinical candidates #drughunter https:// https://t.co/e3nsBeFqjC
Thursday, 8 September 2022
Key Research Articles
Phase II Drug Metabolism | https://t.co/gFiJn6HP9I This poster shows examples of Phase II metabolism, such as: Glucuronidation Sulfonation Glutathione conjugation Methylation Acetylation Amino Acid Conjugation Thanks to HyphaD for their support of this project #drughunter htt https://t.co/2KwLjTEI2s
Saturday, 3 September 2022
Subscribe to:
Posts (Atom)